top of page

2025 Plenary Session Webcasts

2025 LC Webcasts List

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Session 1

Current Landscape in PBC Diagnosis and Treatment

Kris V. Kowdley, MD, AGAF, FAASLD, FACG, FACP

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Session 1

Assessment and Therapy of Symptoms in PBC

Mark G. Swain, MD, MSc, FRCPC, FAASLD, FCAHS

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Session 2

Diagnosis and Management of Met-ALD and ALD Compensated Cirrhosis

Ashwani K. Singal, MD, MS, FACG, FAASLD, AGAF

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Session 2

Early Liver Transplantation (LT) for ALD: What Defines Success After LT?

Sarah R. Lieber, MD, MSCR

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Session 3

Current Management: Obesity and Type-2
Diabetes in MASLD

Christos S. Mantzoros, MD, DSc, PhD, H.C. Mult.

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Session 3

Role of Multi-Disciplinary team in the management of MASLD

Mazen Noureddin, MD, MHSc

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Session 3

Expert Panel Discussion: The Role of NITs

Moderator: Naim Alkhouri, MD

Panelists: Alina Allen, MD; Mandeep Bajaj, MD; and Scott Friedman, MD

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Session 3

Expert Panel Discussion:
Models of Care

Moderator: Sonal Kumar, MD MPH

Panelists: Michael Betel, MS, MSc; Scott Isaacs, MD; Christos Mantzoros, MD, DSc, PhD; and Mazen Noureddin, MD, MHSc

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Session 5

Hepatitis D: Strategies for Treatment and Management

Tatyana Kushner, MD, MSCE

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Session 5

New Developments in Treatment for Hepatitis B

Ira M. Jacobson, MD, FACP, FAASLD, FAGA, FACG

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Session 5

Hepatitis B

Paul Martin, MD

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Session 6

How Do Systemic Therapies & LRT Fit Into the Treatment of Unresectable HCC?

Laura Kulik, MD

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Session 1

Overview of PSC: Mechanisms and Emerging Therapies

Christopher L. Bowlus, MD

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Session 1

Debate: Second-Line Therapy Options in PBC

Moderator: John M Vierling, MD

Speakers: Aparna Goel, MD and Craig Lammert, MD

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Session 2

Treatment Strategies to Reduce Morbidity and Mortality from Alcohol-Associated Liver Disease

Mack C. Mitchell, MD, FAASLD

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Session 3

Practical Use of Non-Invasive Tests in MASH/MASLD Care

Alina M. Allen, MD, MS

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Session 3

MASH Targeted Therapy: Current and Future

Manal F. Abdelmalek MD, MPH

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Session 3

Extrahepatic Diseases Associated With MASLD (CVD, CKD, Cancer and Sarcopenia)

Naim Alkhouri, MD

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Session 3

Expert Panel Discussion:
Management of MASLD

Moderator: Zobair Younossi, MD, MPH

Panelists: Manal Abdelmalek, MD, MPH; Mandeep Bajaj, MD; Scott Isaacs, MD; and
Christos Mantzoros, MD, DSc, PhD

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Session 4

Cirrhosis Case Presentation

Marcelo Kugelmas, MD and Sammy Saab, MD, MPH

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Session 5

Navigating Expanding Guidelines for Hepatitis B

Douglas T. Dieterich, MD

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Session 5

Exploring the Nuances of Hepatitis Vaccination: Are We Doing Enough?

Paul Y Kwo, MD, FACG

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Session 6

Locoregional Therapy for Locally Advanced HCC

Sid Padia, MD

Screenshot 2024-05-15 at 4.43.29 PM 1.png

Session 6

Evolving Role of Neoadjuvant Systemic Therapy for Transplant

Parissa Tabrizian, MD, MSc, FACS

  • Facebook
  • YouTube
  • LinkedIn

© 2025 Focus Medical Communications, LLC

bottom of page